Monday, July 16, 2018 8:05:01 AM
GENE - 1.09 Pre-market now at 1.60/1.61
Genetic Technologies Announces Expansion of Its Range of Genetic Risk Assessment Tests Plus the October Launch of Its New Breast Cancer and Colorectal Cancer Tests
Genetic Technologies Announces Expansion of Its Range of Genetic Risk Assessment Tests Plus the October Launch of Its New Breast Cancer and Colorectal Cancer Tests
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
